Publizoom

Award notice Supplies

Purchase, storage and delivery of live attenuated vaccine against Peste des Petits Ruminants

Public buyer
European Commission, DG SANTE - Health and Food Safety
Brussels
Place of performance
1040 Brussels
not published: buyer's address
Estimated value
€290,340 excl. VAT
Amount awarded
€290,000 excl. VAT
Planned end of contract
19 December 2028
likely re-tender around June 2028
Bids received
6
Procedure
Open procedure
Any company may submit a bid.
Publication
15 January 2025
Notice language
English

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

REASON FOR PURCHASING The Commission has to maintain a stock of at least 250.000 doses of live attenuated Peste des Petits Ruminants (PPR) vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of 250.000 doses of live attenuated vaccine should be replaced quickly, within 4 weeks, when depleted, in order to maintain the Union’s capability to respond to an emergency. PROCUREMENT DESCRIPTION The purpose of the contract is:

  • The purchase of maximum 2.000.000 doses of live attenuated vaccine against PPR. This will be executed with one initial purchase of 250.000 and up to seven (7) replenishments, of maximum 250.000 doses each, upon request from the Commission.
  • The storage of a stock of 250.000 doses, readily available for delivery to any of the destinations listed in point 2.3 (6), that can be replaced, if depleted, partially or totally, up to 7 times until the end of the contract, upon request from the Commission.
  • The timely delivery of maximum 2.000.000 doses divided in as many consignments as needed to any of the destinations listed in point 2.3 (6)
  • The storage of any vaccines in stock at the end of the contract for the remainder of their shelf life
  • The proper destruction and disposal of any unused vaccine at the end of its self life.

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33651690

Winning prices for comparable contracts

A quarter below
€290,000
Median
€403,000
A quarter above
€1,351,075

Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease
European Commission, DG SANTE - Health and Food Safety · 1 October 2026
Huvepharma EOOD €2,385,950
Purchase, storage and delivery of live attenuated vaccine against Sheep Pox
European Commission, DG SANTE - Health and Food Safety · 12 January 2026
VETAL Hayvan Sagligi Urunleri A.S. €403,000
Immunoglobuline humaine normale pour administration intraveineuse
Cliniques universitaires Saint Luc · 22 October 2026
CSL BEHRING €16,277,080
Antimycotica
AZ Delta vzw · 21 October 2026
Arega Pharma NV
Sandoz NV
Fresenius Kabi NV
Pfizer NV
€300,945
Raamovereenkomst voor het leveren van immunoglobulines IV 10%
Universitair Ziekenhuis Gent · 24 September 2026
CSL BEHRING NV €27,360,000

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 26452-2025.